Improving data analysis in leukemia through advanced technology integration

Domain adaptation approaches to unify established and emerging sequencing technologies

NIH-funded research University of Colorado Denver · NIH-11141430

This study is looking at ways to improve how we understand and analyze data about acute myeloid leukemia (AML) by using smart computer techniques to fill in missing information, which could help doctors better predict treatment responses and identify important genetic clues, ultimately leading to better care for patients.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Colorado Denver NIH-funded
Lab location1 site (Aurora, UNITED STATES)
Project IDNIH-11141430 on NIH RePORTER

What this research studies

This research focuses on enhancing the analysis of biological data related to acute myeloid leukemia (AML) by addressing the issue of missing data across different sequencing technologies. By employing machine learning techniques, specifically domain adaptation, the study aims to combine information from established and emerging technologies to fill in gaps in biological observations. This approach will be applied to various biomedical applications, including predicting responses to treatments and identifying genetic signatures from cell-free DNA. Patients may benefit from improved diagnostic and treatment strategies as a result of this research.

Who could benefit from this research

Good fit: Ideal candidates for this research include patients diagnosed with acute myeloid leukemia or related conditions who are undergoing treatment or monitoring.

Not a fit: Patients with conditions unrelated to acute myeloid leukemia or those not undergoing any form of treatment may not receive benefits from this research.

Why it matters

Potential benefit: If successful, this research could lead to more accurate diagnostics and personalized treatment options for patients with acute myeloid leukemia.

How similar studies have performed: Other research has shown promise in using machine learning techniques for data integration in biomedical applications, suggesting that this approach could be effective.

Where this research is happening

Aurora, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Autoimmune Diseases
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.